Podcast Daraxonrasib’s success in treating pancreatic cancer is a reminder that clinical cancer researchers are heroes June 03, 2026
PodcastThe Directors The Directors: NCORP PIs discuss workforce shortages, expanding workload, and crushing burden of regulatory oversight May 29, 2026Vol.52 No.21By Paul Goldberg and Claire Marie Porter
Podcast As FDA’s wheels almost entirely come off, NCI remains sturdy—a cancer moonshot may even be on the horizon May 27, 2026
Podcast The Cancer History Project debuts first de novo book; meanwhile, FDA snafus continue May 20, 2026
Cancer History ProjectFreePodcast “Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research HospitalIn a conversation with Deborah Doroshow, co-authors Chuck Sherr and Bill Evans discuss their collaborative writing process May 15, 2026Vol.52 No.19By Claire Marie Porter
Podcast Prasad’s “deceit,” plus, ODAC’s tough decision against biomarker-based progression assessment (for now) May 13, 2026
Podcast Reforms pending at USPSTF, plus, FDA rejects promising melanoma drug for the second time May 06, 2026
PodcastThe Directors The Directors: UPMC’s Byrd and Jefferson’s Chapman speak about avoiding catastrophism and using bridge funding to keep labs open“There’s a tightening of the belt, and when the belt gets tightened, it has downstream effects.” April 24, 2026Vol.52 No.16By Claire Marie Porter and Paul Goldberg
